Who is Robert Malone • 5 implied HN points • 29 Jan 26
- Current international biosecurity rules strongly ban biological weapons but are institutionally weak and fragmented. They lack verification, enforcement, and do not cover accidental, dual‑use, or self‑propagating risks.
- Low‑probability, high‑consequence biological risks often fall outside existing treaties and can produce irreversible, cross‑border harms. Managing these risks requires proactive international coordination, shared norms, and continuous risk monitoring rather than only national or reactive responses.
- The global framework must shift from mere prohibition to collective risk management by adding verification, common biosafety standards, transparency, and worst‑case preparedness. Strengthening these elements would help align biotechnology innovation with safety and reduce the chance of catastrophic global events.